BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10830155)

  • 1. Gastrointestinal adverse effects with divalproex sodium and valproic acid.
    Wagner PG; Welton SR; Hammond CM
    J Clin Psychiatry; 2000 Apr; 61(4):302-3. PubMed ID: 10830155
    [No Abstract]   [Full Text] [Related]  

  • 2. The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study.
    Zarate CA; Tohen M; Narendran R; Tomassini EC; McDonald J; Sederer M; Madrid AR
    J Clin Psychiatry; 1999 Apr; 60(4):232-6. PubMed ID: 10221283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal tolerance of divalproex sodium.
    Wilder BJ; Karas BJ; Penry JK; Asconape J
    Neurology; 1983 Jun; 33(6):808-11. PubMed ID: 6405304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side effect profile of enteric-coated divalproex sodium versus valproic acid.
    Levine J; Chengappa KN; Parepally H
    J Clin Psychiatry; 2000 Sep; 61(9):680-1. PubMed ID: 11030493
    [No Abstract]   [Full Text] [Related]  

  • 5. A naturalistic comparison of adverse effects between slow titration and loading of divalproex sodium in psychiatric inpatients.
    Lima WJ; Dopheide JA; Kramer BA; Earhart CA; Wincor MZ
    J Affect Disord; 1999; 52(1-3):261-7. PubMed ID: 10357044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses.
    Puryear LJ; Kunik ME; Workman R
    J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):234-7. PubMed ID: 8561838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of patient preference and side effects in patients switched from divalproex sodium delayed release to divalproex sodium extended release.
    Minirth FB; Neal V
    J Clin Psychopharmacol; 2005 Feb; 25(1):99-101. PubMed ID: 15643111
    [No Abstract]   [Full Text] [Related]  

  • 8. Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions.
    Wassef AA; Winkler DE; Roache AL; Abobo VB; Lopez LM; Averill JP; Mian AI; Overall JE
    Am J Psychiatry; 2005 Feb; 162(2):330-9. PubMed ID: 15677599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy: Valproic acid.
    Koch-Weser J; Browne TR
    N Engl J Med; 1980 Mar; 302(12):661-6. PubMed ID: 6766529
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastrointestinal side-effects after switch to generic valproic acid.
    Sherwood Brown E; Shellhorn E; Suppes T
    Pharmacopsychiatry; 1998 May; 31(3):114. PubMed ID: 9657239
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
    Lunde JL; Nelson RE; Storandt HF
    Pharmacotherapy; 2007 Aug; 27(8):1202-5. PubMed ID: 17655519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of food on the serum concentration profile of enteric-coated valproic acid.
    Fischer JH; Barr AN; Paloucek FP; Dorociak JV; Spunt AL
    Neurology; 1988 Aug; 38(8):1319-22. PubMed ID: 3135514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients.
    Sherr JD; Kelly DL
    Psychiatr Serv; 1998 Oct; 49(10):1355-7. PubMed ID: 9779912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of valproate.
    Schmidt D
    Epilepsia; 1984; 25 Suppl 1():S44-9. PubMed ID: 6425046
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended-Release Tablets in Healthy Participants and Patients with Psychiatric Disorders.
    Remmerie B; Ariyawansa J; De Meulder M; Coppola D; Berwaerts J
    J Clin Pharmacol; 2016 Jun; 56(6):683-92. PubMed ID: 26412032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divalproex sodium vs. valproic acid: drug utilization patterns, persistence rates and predictors of hospitalization among VA patients diagnosed with bipolar disorder.
    Iqbal SU; Cunningham F; Lee A; Wang S; Hamed A; Miller DR; Ren X; Kazis L
    J Clin Pharm Ther; 2007 Dec; 32(6):625-32. PubMed ID: 18021341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications.
    Dutta S; Reed RC; O'Dea RF
    Ann Pharmacother; 2006 Apr; 40(4):619-25. PubMed ID: 16569797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excipients in valproic acid syrup may cause diarrhea: a case report.
    Veerman MW
    DICP; 1990 Sep; 24(9):832-3. PubMed ID: 2260339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agitation as a paradoxical effect of divalproex sodium: a case report.
    Sobhan T; Munoz C; Ryan W
    J Neuropsychiatry Clin Neurosci; 2001; 13(4):528-30. PubMed ID: 11748324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.